Malaria Articles & Analysis

How to make big strategies and specific program ideas work will be the focus of a rare cross-sector mix of senior executives and program implementers at the Global Health Action conference in Washington June 7-8. In addition, the conference will emphasize funding and partnership opportunities, both public-private and innovative 'collective actions,' which include collaboration among multiple ...

By CSRwire - Corporate Social Responsibility Newswire

On April 25th people across the globe take part in a wide range of activities to mark World Malaria Day. For half the world every day is malaria day - a day to keep up the fight against this killer disease. The World Malaria Day theme from 2013 – 2015 is ‘Invest in the future, defeat malaria’. The theme provides a common platform for countries to showcase their successes in ...

By DelAgua Group

Artesunate for Injection 110 mg, powder and solvent for solution is approved by FDA for initial treatment of severe malaria in adult and pediatric patients. Artesunate for Injection is in a group of drugs known as “artemisinin derivatives” and is on the World Health Organization Model List of Essential Medicines. Since 2007, Investigational Intravenous (IV) Artesunate has been ...

By Amivas (US), LLC

TROY, New York, August 29, 2007 (ENS) - Malaria kills over one million people around the world, mostly young children. And the problem is growing as the Earth heats up due to global warming. Outbreaks of the deadly parasitic disease are spreading into temperate latitudes a little more each year, health officials report. Now an international team led by researchers from Rensselaer Polytechnic ...

By Environment News Service (ENS)

Government, business and civil society leaders gathered at the United Nations last week to launch a global campaign to reduce malaria deaths, currently at more than 1 million each year, to near zero by 2015, with an initial commitment of nearly a US$3bn. The Global Malaria Action Plan (GMAP) aims to cuts deaths and illness by 2010 to half their 2000 levels by scaling up access to ...

By United Nations

Cuba has announced plans to build biolarvicide factories in Brazil and several African countries in a bid to tackle malaria and dengue fever. Biolarvicides are biological products that are added to water to kill mosquitoes at the larval stage. Labiofam — the Cuban laboratory in charge of the project — has been producing two biolarvicides, Bactivec and Griselesf, since the 1990s. The ...

By SciDev.Net

Biodiversity could play a key role in preventing future outbreaks of malaria in tropical forests, according to a new study. Results indicate that a greater number of mosquito species could increase competition for mosquitoes that spread malarial parasites, whilst more vertebrate species could increase the likelihood that malarial parasites end up in ‘dead-end hosts’ that are unable to ...

By European Commission, Environment DG

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the pre-print publication of data from a Phase 2b clinical trial in children demonstrating 77 percent efficacy for a malaria vaccine candidate, R21, created by the University of Oxford that includes Novavax' Matrix-M™ adjuvant and is licensed to Serum ...

By Novavax

The Jenner Institute at Oxford University, together with partners Imaxio and GSK, has started a phase I clinical trial of a novel vaccine candidate aimed at blocking transmission of malaria. Around half the world’s population is at risk of malaria and the disease led to an estimated 584,000 deaths in 2013. MosquirixTM, a malaria vaccine candidate developed by GSK, has just received a ...

By IMAXIO S.A.

Mosquitoes bring a large number of serious Krankeiten to people. Our ex-mosquito product acts biologically and environmentally compatible at all stages of mosquitoes. Other creatures are not harmed. The output is via standard spray systems and can therefore be used on all surfaces quickly and inexpensively. the more time is very fast and creates for months remedy the annoying insects. With ...

By Oil Dissolver GmbH

Bestnet Europe Ltd. has announced a donation of 2600 Netprotect Long Lasting Insecticide Incorporated Mosquito Nets (LLINs) to JCI (Junior Chamber International) to support their participation in the Budapest-Bamako Great African Run, the world's largest charity rally. JCI and the JCI Nothing But Nets campaign will hit the ground running in 2011 with the Budapest-Bamako Great African Run. The ...

By CSRwire - Corporate Social Responsibility Newswire

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria. The research, conducted in collaboration with the University of Washington, was published in the peer-reviewed journal, Nature Partner ...

By Lumen Bioscience, Inc.

Government delegates to the United Nations' Stockholm Convention on persistent organic pollutants (POPs) have added nine new chemicals to its list of substances that governments must control. Environmental NGOs have welcomed the move but are disappointed by the inadequacy and inconsistency of control measures approved for three the listed chemicals. Delegates at the meeting, held in Geneva in ...

By Health and Environment Alliance (HEAL)

African health and environment ministers attending a United Nations-sponsored conference which concluded this week in Gabon have agreed to form an alliance to try to reduce environmental threats to human health and well-being. The Libreville Declaration, named after the Gabonese capital where the four-day conference was held, commits governments in the region to take measures to stimulate the ...

By United Nations

Aesther Healthcare (NASDAQ:AEHA) announced this morning that it has inked a common stock purchase agreement with White Lion Capital that will provide up to $75 million to its combination target Ocean Biomedical. Following close, Ocean may direct White Lion to purchase shares in the company worth up to $2 million or 67% of the five-day average daily trading volume. White Lion previously signed an ...

By Ocean Biomedical

The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule therapies in collaboration with the foundation’s global network Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today $2.3M in grant ...

By Atomwise Inc.

Sirenas, LLC ("Sirenas"), a biotechnology company harnessing computational approaches to discover therapeutics derived from nature's chemistry, announced that it has received a new grant from the Bill & Melinda Gates Foundation to advance ATLANTIS™, the company's proprietary drug discovery technology. With today's announcement, Sirenas has now received two research grant awards from ...

By Sirenas

Independent India should learn lessons from the deadly malaria epidemics that swept many parts of the country in the last century, attributable to indiscriminate canal building and related projects by the then rulers, a new study suggests. The study by Elizabeth Whitcombe, visiting senior research scholar at the earth system science interdisciplinary centre, University of Maryland, US, in the ...

By SciDev.Net

As delegates gather at the International AIDS Conference (3-8 August), the World Health Organization (WHO) and the World Bank address the pressing global debate around health systems and initiatives in specific aspects of health, nutrition and population. Critics claim that disease-specific initiatives are eroding already weak health systems, while others assert that weak health systems are ...

By World Health Organization (WHO)

Imaxio, a biotech company specializing in immunology announces today the sale of Trolovol® (D-penicillamine), a drug for human usage indicated for an orphan disease affecting around 1,200 patients in France. The transaction was facilitated by CMC Consulting Group. This sale is aligned with Imaxio’s willingness to refocus its business on vaccines. This is the result of several years of ...

By IMAXIO S.A.